Benjamin A. Rogers
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.5%
- Escherichia coli research studies
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- Antibiotic Use and Resistance 16
-
- Antibiotic Resistance in Bacteria 21
- Co-authors
- David L. PatersonHanna E. SidjabatMinyon AventBenjamin LazarusJoanne L. MollingerAllen ChengMark A. SchembriDanilo Gomes Moriel
- Journals
- Journal of Antimicrobial Chemotherapy (6 papers)International Journal of Antimicrobial Agents (4 papers)The Medical Journal of Australia (4 papers)Clinical Infectious Diseases (3 papers)Trials (3 papers)
- Partner nations
- AustraliaCanadaNew Zealand
In The Last Decade
Benjamin A. Rogers
54 papers receiving 2.3k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Molecular Medicine 1.4k
- Endocrinology 858
- Applied Microbiology and Biotechnology 298
- Clinical Biochemistry 259
- Pollution 356
Countries citing papers authored by Benjamin A. Rogers
This map shows the geographic impact of Benjamin A. Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin A. Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin A. Rogers more than expected).
Fields of papers citing papers by Benjamin A. Rogers
This network shows the impact of papers produced by Benjamin A. Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin A. Rogers. The network helps show where Benjamin A. Rogers may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Benjamin A. Rogers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2022 | 27 | |
| 11 | 2021 | 1 | |
| 12 | 2020 | 2 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 7 | |
| 15 | 2020 | 7 | |
| 16 | 2019 | 25 | |
| 17 | 2014 | 6 | |
| 18 | 2014 | 204 | |
| 19 | 2012 | 45 | |
| 20 | Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain Hit paper breakdown → | 2010 | 578 |
About Benjamin A. Rogers
Benjamin A. Rogers is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Endocrinology, Clinical Biochemistry and Biological Psychiatry, having authored 59 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (21 papers), Antibiotic Use and Resistance (16 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Escherichia coli research studies (10 papers), Bacterial Identification and Susceptibility Testing (9 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Urinary Tract Infections Management (5 papers) and Infective Endocarditis Diagnosis and Management (4 papers). The work is most often cited by research in Molecular Medicine (1.4k citations), Endocrinology (858 citations), Applied Microbiology and Biotechnology (298 citations), Clinical Biochemistry (259 citations) and Pollution (356 citations). Benjamin A. Rogers has collaborated with scholars based in Australia, Canada and New Zealand. Frequent co-authors include David L. Paterson, Hanna E. Sidjabat, Minyon Avent, Benjamin Lazarus, Joanne L. Mollinger, Allen Cheng, Mark A. Schembri, Danilo Gomes Moriel, Makrina Totsika and Minh‐Duy Phan. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents, The Medical Journal of Australia, Clinical Infectious Diseases and Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.